A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and effectiveness of fluconazole as treatment for acute cryptococcal
meningitis in patients who have had an unsatisfactory response to or have experienced
unacceptable toxicity with amphotericin B.
Phase:
N/A
Details
Lead Sponsor:
Pfizer
Treatments:
Amphotericin B Fluconazole Liposomal amphotericin B